Cargando…
Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals
BACKGROUND: The SCID-hu Thy/Liv mouse model of HIV-1 infection is a useful platform for the preclinical evaluation of antiviral efficacy in vivo. We performed this study to validate the model with representatives of all four classes of licensed antiretrovirals. METHODOLOGY/PRINCIPAL FINDINGS: Endpoi...
Autores principales: | Stoddart, Cheryl A., Bales, Cheryl A., Bare, Jennifer C., Chkhenkeli, George, Galkina, Sofiya A., Kinkade, April N., Moreno, Mary E., Rivera, José M., Ronquillo, Rollie E., Sloan, Barbara, Black, Paul L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925140/ https://www.ncbi.nlm.nih.gov/pubmed/17668043 http://dx.doi.org/10.1371/journal.pone.0000655 |
Ejemplares similares
-
Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice
por: Stoddart, Cheryl A., et al.
Publicado: (2007) -
Human Herpesvirus 6 (HHV-6) Causes Severe Thymocyte Depletion in SCID-hu Thy/Liv Mice
por: Gobbi, Alberto, et al.
Publicado: (1999) -
Experimental Transmission of Kaposi's Sarcoma–Associated Herpesvirus (Kshv/Hhv-8) to Scid-Hu Thy/Liv Mice
por: Dittmer, D., et al.
Publicado: (1999) -
Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor: EQUIPOTENT TO
C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV
MICE
por: Stoddart, Cheryl A., et al.
Publicado: (2008) -
Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model
por: Stoddart, Cheryl A., et al.
Publicado: (2022)